Regulation & Policy Industry Analysis

Buy the information you need on Pharmaceutical Regulation & Policy. Our catalogue of reports includes specific information on Pharma Compliance, Patent Protection and Drug Registration.

Your filters clear all
None selected
clear

Discounts and Delivery

clear

Price

Change currency
Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market (GBI00736)
Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market Summary GBI Research's report ""Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market"" looks at the regulatory...
May 2013£2,175€2,581$3,500
The Path to Product Inclusion in Clinical Guidelines (FWD00095)
Strategies for SuccessClinical guidelines are taking hold in the practice of medicine. Though not always voluntarily followed in real-world patient care, they increasingly form the basis of formulary and reimbursement decisions, as...
Feb 2013£345€409$556
IVD Procedure Volume and Pricing Analysis (KAL00255)
This report examines the global procedure volumes for IVD and laboratory tests. It covers only commercialized tests, specifically excluding those that are developmental or used primarily for research purposes.. Point...
Jan 2013£2,480€2,942$3,995
IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Swtizerland (IMS00266)
The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS...
Dec 2012£415€492$665
Publication Practices for Compliance and Credibility (FWD00090)
Don't miss this up-to-the-minute report on publication practices. Pharma's efforts to disseminate the results of its clinical research have never been under such intense scrutiny. Such high levels of suspicion...
Dec 2012£415€492$668
The World Market for Stents (KAL00117)
Drug-Eluting and Bare Metal Product Markets in US, EU, Japan, India, China and ROWThe coronary stents industry is a highly competitive one in which innovation occurs rapidly and the technology landscape evolves at a fast pace. As the global population is aging and...
Oct 2012£2,480€2,942$3,995
Advisory Committees and Speaker Bureaux (FWD00086)
Ensuring CompliancePharma is faced with increasing constraints on physician participation in its advisory board and speaker bureau programs. The Physician Payment Sunshine Act, which goes into effect in the US in...
Oct 2012£535€635$862
Pharmaceutical Pricing and Reimbursement (GBI00032)
Adoption of Health Technology Assessments (HTA) Optimizes Drug Pricing and Accelerates Reimbursement Decision-MakingPharmaceutical Pricing and Reimbursement - Adoption of Health Technology Assessments (HTA) Optimizes Drug Pricing and Accelerates Reimbursement Decision-Making Summary GBI Research, leading business intelligence provider has released its latest research report, entitled...
Sep 2012£2,175€2,581$3,500
GLOBAL PHARMA SCREEN FOR TOP PICK (MPS00024)
We recommend MRK and Roche as our Top pick from Global pharma space. NVS as well is interesting, trading at defensive valuations, but except for deconsolidation, there are no major...
Jul 2012£310€368$500
Latest Guide to Chinese Pharmaceutical GMP Regulations (ACC00019)
China possesses a fourth population in the world and has one of the largest drug markets round the world. By 2011, sales on the Chinese drug market have reached RMB...
Jul 2012£465€552$750
China's Guidebook for Pharmaceutical Patent Protection (ACC00008)
Description China possesses a fourth population in the world and has one of the largest drug markets round the world. By 2011, sales on the Chinese drug market have reached RMB...
May 2012£930€1,103$1,495
Drug Price Cuts in Top Five Countries of Europe (GBI00392)
Tougher Reference Pricing Environment and Drug Price Freeze through 2013 Expected to Drive Down Healthcare CostsDrug Price Cuts in Top Five Countries of Europe - Tougher Reference Pricing Environment and Drug Price Freeze through 2013 Expected to Drive Down Healthcare Costs Summary GBI Research, the leading business...
May 2012£2,175€2,581$3,500
Regulatory Intelligence on Medical Device Recalls (GBI00386)
Ineffective Process Control, Defects in Design of Device, Software or Other Components are the Major Reasons for RecallRegulatory Intelligence on Medical Device Recalls - Ineffective Process Control, Defects in Design of Device, Software or Other Components are the Major Reasons for Recall Summary GBI Research report, "Regulatory Intelligence on...
Apr 2012£2,175€2,581$3,500
Pricing and Reimbursement in Generics (GBI00381)
European Austerity Measures and Healthcare Cost Containment Puts Innovation-Driven Pharma Companies under PressurePricing and Reimbursement in Generics - European Austerity Measures and Healthcare Cost Containment Puts Innovation-Driven Pharma Companies under Pressure Summary GBI Research, the leading business intelligence provider, has released its latest research...
Apr 2012£2,175€2,581$3,500
IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Poland (IMS00202)
The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS...
Mar 2012£415€492$665
IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Denmark (IMS00219)
The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS...
Mar 2012£415€492$665
IMS Pharmaceutical Pricing & Reimbursement Concise Guide: India (IMS00204)
The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS...
Mar 2012£415€492$665
IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Brazil (IMS00215)
The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS...
Mar 2012£415€492$665
IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Hungary (IMS00203)
The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS...
Mar 2012£415€492$665
IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Mexico (IMS00199)
The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS...
Mar 2012£415€492$665
IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Norway (IMS00201)
The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS...
Mar 2012£415€492$665
IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Turkey (IMS00192)
The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS...
Mar 2012£415€492$665
Pricing and Reimbursement of The Healthcare System in India (GBI00359)
Low Levels of Drug Reimbursement Lead to a High out-of-Pocket ExpenditurePricing and Reimbursement of the Healthcare System in India - Low Levels of Drug Reimbursement Lead to a High Out-Of-Pocket Expenditure Summary GBI Research, the leading business intelligence provider, has released its...
Mar 2012£2,175€2,581$3,500
New Thinking in Patient Adherence (FWD00081)
Patient non-adherence is estimated to represent $290 billion per year in avoidable medical expenses in the United States alone. Consumers' motivations for non-compliance are complex; up to 80% of people...
Mar 2012£495€587$797
A Comprehensive Guidebook for Foreign Pharmaceutical Companies:Latest Chinese Regulations for Imported Drug Registration (ACC00001)
China Pharmaceutical Guidebook Series (1) (4th edition)In China, the process of application and approval for imported drug registration is very complex, because the Chinese pharmaceutical authorities administer and control this process by exorbitant administrative measures and...
Mar 2012£465€552$750